Bio-Techne Corporation reported a net profit of $54.622 million, or $0.35 per share, for the fourth quarter of fiscal 2026, reversing a net loss of $17.677 million, or $0.11 per share, a year earlier. Total operating expenses fell to $137.117 million from $222.672 million, while net sales rose to $321.191 million from $316.964 million. Excluding items, earnings were $82.436 million, or $0.52 per share, slightly below the prior-year's $82.472 million, or $0.53 per share.
Bio-Techne CorpQ4 profit swing to net income on lower expenses and higher sales
